Validose Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- (In Progress)
- Latest Deal Amount
-
$3M
- Investors
-
3
Validose General Information
Description
Developer of an objective remote treatment data platform designed to verify medication use and treatment execution outside clinical settings in real time. The company's platform combines connected, format-adaptable devices with multi-signal dose confirmation, longitudinal treatment data and personalized adherence coaching, enabling biopharmaceutical companies, clinical research organizations and care teams to improve trial oversight, patient engagement and treatment outcomes.
Contact Information
Website
www.validose.comCorporate Office
- 63 Flushing Avenue
- Building 303, Suite 807
- Brooklyn, NY 11205
- United States
Corporate Office
- 63 Flushing Avenue
- Building 303, Suite 807
- Brooklyn, NY 11205
- United States
Validose Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | $3M | In Progress | ||||
| 1. Seed Round | 06-Jan-2025 | Completed | Product Development |
Validose Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Validose Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Validose Patents
Validose Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240285473-A1 | Smart pill dispenser prescription treatment system | Pending | 06-Jul-2021 | ||
| US-12766279-B2 | System and method for locking a controlled medical therapy device | Active | 03-Feb-2020 | ||
| US-20210236752-A1 | System and method for locking a controlled medical therapy device | Active | 03-Feb-2020 | ||
| WO-2021158592-A1 | System and method for locking a controlled medical therapy device | Inactive | 03-Feb-2020 | ||
| US-12599731-B2 | System and method for sensing usage of a controlled medical therapy device | Active | 03-Feb-2020 | A61M15/08 |
Validose Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Validose Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 10XBeta | VC-Backed Company | Minority | ||
| Bauer Family Office's Technology for Humanity | Venture Capital | Minority | ||
| Interstate Fusion Ventures | Venture Capital | Minority |
Validose FAQs
-
When was Validose founded?
Validose was founded in 2024.
-
Where is Validose headquartered?
Validose is headquartered in Brooklyn, NY.
-
What is the size of Validose?
Validose has 10 total employees.
-
What industry is Validose in?
Validose’s primary industry is Drug Delivery.
-
Is Validose a private or public company?
Validose is a Private company.
-
What is Validose’s current revenue?
The current revenue for Validose is .
-
How much funding has Validose raised over time?
Validose has raised $2M.
-
Who are Validose’s investors?
10XBeta, Bauer Family Office's Technology for Humanity, and Interstate Fusion Ventures have invested in Validose.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
